Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma

Oncotarget

Volumn 7, Issue 13, 2016, Pages 17111-17128

  Hamada, Junichi ^a,b   Shoda, Katsutoshi ^a,b   Masuda, Kiyoshi ^a   Fujita, Yuji ^a,b   Naruto, Takuya ^a   Kohmoto, Tomohiro ^a,c   Miyakami, Yuko ^a,c   Watanabe, Miki ^a,c   Kudo, Yasusei ^a   Fujiwara, Hitoshi ^b   Ichikawa, Daisuke ^b   Otsuji, Eigo ^b   Imoto, Issei ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Isoform; Oncogene; RNA binding protein; T cell intracellular antigen 1

Indexed keywords

CYCLIN A2; ISOPROTEIN; MESSENGER RNA; RNA BINDING PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; T CELL INTRACELLULAR ANTIGEN 1; UNCLASSIFIED DRUG; NUCLEOLYSIN TIA 1 ISOFORM P40; TIA1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CCNA2 GENE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKP2 GENE; TUMOR PROMOTION; AGED; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; T-CELL INTRACELLULAR ANTIGEN-1;

EID: 84971631998     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7937     Document Type: Article

References (52)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359-386.
2. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014; 371: 2499-2509.
3. Okines A, Cunningham D, Chau I. Targeting the human EGFR family in esophagogastric cancer. Nat Rev Clin Oncol. 2011; 8:492-503.
4. Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell. 2009; 136:777-793.
5. Wurth L, Gebauer F. RNA-binding proteins, multifaceted translational regulators in cancer. Biochim Biophys Acta. 2015; 1849:881-886.
6. Darnell RB. RNA regulation in neurologic disease and cancer. Cancer Res Treat. 2010; 42:125-129.
7. Kechavarzi B, Janga SC. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 2014; 15:R14.
8. Audic Y, Hartley RS. Post-transcriptional regulation in cancer. Biol Cell. 2004; 96:479-498.
9. Wang J, Liu Q, Shyr Y. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis. BMC Genomics. 2015; 16:S5.
10. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P.A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell. 1991; 67:629-639.
11. Izquierdo JM, Valcárcel J. Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities. Control of TIA-1 isoform ratio by TIA-1-related protein. J Biol Chem. 2007; 282:19410-19417.
12. Reyes R, Alcalde J, Izquierdo JM. Depletion of T-cell intracellular antigen proteins promotes cell proliferation. Genome Biol. 2009; 10:R87.
13. Subramaniam K, Ooi LL, Hui KM. Transcriptional down-regulation of IGFBP-3 in human hepatocellular carcinoma cells is mediated by the binding of TIA-1 to its AT-rich element in the 3′-untranslated region. Cancer Lett. 2010; 297:259-268.
14. Izquierdo JM, Alcalde J, Carrascoso I, Reyes R, Ludeña MD.Knockdown of T-cell intracellular antigens triggers cell proliferation, invasion and tumour growth. Biochem J. 2011; 435:337-344.
15. Zhang T, Delestienne N, Huez G, Kruys V, Gueydan C. Identification of the sequence determinants mediating the nucleo-cytoplasmic shuttling of TIAR and TIA-1 RNA-binding proteins. J Cell Sci. 2005; 118:5453-5463.
16. Piecyk M, Wax S, Beck ARP, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. Embo Journal. 2000; 19:4154-4163.
17. Wang Z, Kayikci M, Briese M, Zarnack K, Luscombe NM, Rot G, Zupan B, Curk T, Ule J. iCLIP predicts the dual splicing effects of TIA-RNA interactions. PLoS Biol. 2010; 8:e1000530.
18. López de Silanes I, Galbán S, Martindale JL, Yang X, Mazan-Mamczarz K, Indig FE, Falco G, Zhan M, Gorospe M.Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol. 2005; 25:9520-9531.
19. Yamasaki S, Stoecklin G, Kedersha N, Simarro M, Anderson P. T-cell intracellular antigen-1 (TIA-1)-induced translational silencing promotes the decay of selected mRNAs. J Biol Chem. 2007; 282:30070-30077.
20. Damgaard CK, Lykke-Andersen J. Translational coregulation of 5′TOP mRNAs by TIA-1 and TIAR. Genes Dev. 2011; 25:2057-2068.
21. Gottschald OR, Malec V, Krasteva G, Hasan D, Kamlah F,Herold S, Rose F, Seeger W, Hänze J. TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1α pathway. J Mol Cell Biol. 2010; 2:345-356.
22. Izquierdo JM, Majós N, Bonnal S, Martínez C, Castelo R, Guigó R, Bilbao D, Valcárcel J. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell. 2005; 19:475-484.
23. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K,Akiyoshi T. p27 expression and gastric carcinoma. Nat Med. 1997; 3:593.
24. Shapira M, Ben-Izhak O, Linn S, Futerman B, Minkov I, Hershko DD. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer. 2005; 103:1336-1346.
25. Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC, Hsing CH, Lee SW, Sheu MJ, Lee HH, Shiue YL, Huang HY, Pan HY, Li CF et al. SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential. Tumour Biol. 2013; 34:1107-1117.
26. Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer. 2008; 112:1415-1424.
27. Yasmeen A, Berdel WE, Serve H, Muller-Tidow C. E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2003; 3:617-633.
28. Sanchez-Jimenez C, Ludena MD, Izquierdo JM. T-cell intracellular antigens function as tumor suppressor genes. Cell Death Dis. 2015; 6:e1669.
29. Shyu AB, Wilkinson MF. The double lives of shuttling mRNA binding proteins. Cell. 2000; 102:135-138.
30. Zhang C, Xue G, Bi J, Geng M, Chu H, Guan Y, Wang J,Wang B. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma. Tumour Biol. 2014; 35:73-80.
31. Kedersha NL, Gupta M, Li W, Miller I, Anderson P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol. 1999; 147:1431-1442.
32. Wilson GM, Lu J, Sutphen K, Sun Y, Huynh Y, Brewer G. Regulation of A + U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1. J Biol Chem. 2003; 278:33029-33038.
33. Arao Y, Kuriyama R, Kayama F, Kato S. A nuclear matrix-associated factor, SAF-B, interacts with specific isoforms of AUF1/hnRNP D. Arch Biochem Biophys. 2000; 380:228-236.
34. Inoue A, Arao Y, Omori A, Ichinose S, Nishio K, Yamamoto N,Kinoshita Y, Mita S. Identification of S1 proteins B2, C1 and D1 as AUF1 isoforms and their major role as heterogeneous nuclear ribonucleoprotein proteins. Biochem J. 2003; 372:775-785.
35. Zucconi BE, Ballin JD, Brewer BY, Ross CR, Huang J, Toth EA,Wilson GM. Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation of bound RNA ligands. J Biol Chem. 2010; 285:39127-39139.
36. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet. 2007; 8:533-543.
37. Ross J. mRNA stability in mammalian cells. Microbiol Rev. 1995; 59:423-450.
38. Eberhardt W, Doller A, Akoolel-S, Pfeilschifter J. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther. 2007; 114:56-73.
39. Lopez de Silanes I, Quesada MP and Esteller M. Aberrant regulation of messenger RNA 3′-untranslated region in human cancer. Cell Oncol. 2007; 29:1-17.
40. Anderson P, Kedersha N. Stressful initiations. J Cell Sci. 2002; 115:3227-3234.
41. Brewer G. An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol Cell Biol. 1991; 11:2460-2466.
42. Kullmann M, Gopfert U, Siewe B, Hengst L. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev. 2002; 16:3087-3099.
43. Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD, Gorospe M. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA. 2003; 100:8354-8359.
44. Xu N, Chen CY, Shyu AB. Versatile Role for hnRNP D Isoforms in the Differential Regulation of Cytoplasmic mRNA Turnover. Mol Cell Biol. 2001; 21:6960-6971.
45. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992; 69:277-284.
46. Shiozaki A, Yamagishi H, Itoi H, Fujiwara H, Kikuchi S, Okamoto K, Ichikawa D, Fuji N, Ochiai T, Sonoyama T, Ueda Y. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer. Oncol Rep. 2005; 13:667-672.
47. Sobin LH, Gospodarowicz MK, Wittekind C and International Union against Cancer. (2010). TNM classification of malignant tumours. (Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell).
48. Masuda K, Abdelmohsen K, Kim MM, Srikantan S, Lee EK, Tominaga K, Selimyan R, Martindale JL, Yang X, Lehrmann E, Zhang Y, Becker KG, Wang JY, et al. Global dissociation of HuR-mRNA complexes promotes cell survival after ionizing radiation. EMBO J. 2011; 30:1040-1053.
49. Akaike Y, Masuda K, Kuwano Y, Nishida K, Kajita K, Kurokawa K, Satake Y, Shoda K, Imoto I, Rokutan K. HuR regulates alternative splicing of the TRA2beta gene in human colon cancer cells under oxidative stress. Mol Cell Biol. 2014; 34:2857-2873.
50. Kurokawa K, Akaike Y, Masuda K, Kuwano Y, Nishida K,Yamagishi N, Kajita K, Tanahashi T, Rokutan K. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells. Oncogene. 2014; 33:1407-1417.
51. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4:44-57.
52. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37:1-13.